Islatravir (MK-8591) is an antiretroviral drug with a novel mode of operation that has excited a lot of interest in the last two years because of its extraordinary persistence in the body. This means it may only need to be given once a week as an HIV treatment, and a subcutaneous implant that releases the drug might only… Read More: Once-a-month PrEP pill easily passes its first big test »
New HIV diagnoses in gay and bisexual men fell by 20% after the implementation of a publicly funded PrEP programme in Scotland, while HIV incidence in a large cohort of men attending sexual health clinics fell by 43%, Professor Claudia Estcourt of Glasgow Caledonian University and colleagues report in AIDS. “We show that it is… Read More: Huge fall in new HIV infections after roll-out of PrEP… »
A proactive, outreach-based service for people who inject drugs has successfully delivered the HIV prevention medication PrEP in the midst of Glasgow’s HIV outbreak, Dr Ceilidh Grimshaw of Sandyford told the virtual British HIV Association conference this week. Very few PrEP programmes for people who inject drugs have reported results and ongoing engagement with healthcare… Read More: Glasgow outreach service shows the feasibility of PrEP for people… »